eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Peckforton Pharmaceuticals

Crewe Hall, Crewe, Cheshire, CW1 6UL, UK
Telephone: +44 (0)1270 582 255
Fax: +44 (0)1270 582 299
E-mail: med.info@peckforton.com
WWW: http://www.peckforton.com
Medical Information Direct Line: +44 (0)1270 582 255
Medical Information Fax: +44 (0)1270 582 299

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 20/02/2008
SPC Altacite Plus


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Altacite Plus Suspension

Asda Indigestion Liquid

Sainsbury's Spearmint Indigestion Liquid


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 5ml contains 500mg of Hydrotalcite light and 125mg of Dimethicone (activated)


Go to top of the page
3. PHARMACEUTICAL FORM

Suspension


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Altacite Plus Suspension is indicated for the symptomatic relief of the following conditions: -

Dyspepsia: flatulence and abdominal: hyperacidity; gastritis: peptic ulceration; heartburn especially when associated with oesophagitis or hiatus hernia and heartburn and pregnancy.


Go to top of the page
4.2 Posology and method of administration

Route of administration: Oral

Adults

10ml suspension between meals and at bedtime.

Elderly:

No specific recommendations in the elderly.

Children (8-12 years)

Half the adult dose.


Go to top of the page
4.3 Contraindications

None known


Go to top of the page
4.4 Special warnings and precautions for use

None Known


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Altacite Plus may reduce intestinal absorption of tetracycline's


Go to top of the page
4.6 Pregnancy and lactation

For Co-simalcite 125/500 no clinical data on exposed pregnancies are available

Caution should be exercised when prescribing to pregnant women


Go to top of the page
4.7 Effects on ability to drive and use machines

Not applicable


Go to top of the page
4.8 Undesirable effects

Side effects are uncommon. Diarrhoea and vomiting have been reported but have ceased on withdrawal of the therapy.


Go to top of the page
4.9 Overdose

Overdose has not been reported. There is no evidence of absorption of Hydrotalcite in man. Investigations in healthy human volunteers have shown no elevation of serum aluminium or magnesium levels on administration of Hydrotalcite at therapeutic dosage for a continuous period of 28 days.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Dimethicone is inert oil, which is tissue adherent and water repellent, it is therefore a mucosal protective and anti-foaming agent, which can reduce flatulence.


Go to top of the page
5.2 Pharmacokinetic properties

No data on pharmacokinetic studies of Altacite Plus Suspension are available. The active ingredients hydrotalcite and activated dimethicone are not generally absorbed.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber, which are additional to that already included in the other sections of the SmPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Sodium carboxymethylcellulose, tween 80, sorbitan mono-oleate, sorbitan tristearate, glyceryl monostearate, aerosil, methylcellulose 2500, microcystalline cellulose, bronopol, spearmint polvaromas 077, saccharin sodium, chloroform and purified water.


Go to top of the page
6.2 Incompatibilities

None known


Go to top of the page
6.3 Shelf life

60 Months. After first opening the container, discard the contents 28 days after opening.


Go to top of the page
6.4 Special precautions for storage

Store between 4°C and 25°C


Go to top of the page
6.5 Nature and contents of container

High-density polyethylene bottles with standard jaypour caps or amber glass bottles with tamper evident polyethylene screw cap fitted with a polyethylene coated wool seal.

Bottle of 500ml as a pharmacy item or 100ml (and 250ml) as a general sales item.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Peckforton Pharmaceuticals Ltd.

Crewe Hall Crewe, Cheshire, CW1 6UL


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 15760/0002


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

3 June 1999


Go to top of the page
10. DATE OF REVISION OF THE TEXT

April 2004



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/20577/SPC/


Active Ingredients/Generics

 
   simeticone
   hydrotalcite